Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Limin Shang

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Transplantation|October 24, 2014
Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockadeLaurianne Giovannoni, Yannick D Muller, Stéphanie Lacotte, et al.
Cell Chemical Biology|October 21, 2021
An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunityYuehui Zhang, Limin Shang, Jing Zhang, et al.
Inflammatory Bowel Diseases|June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesisMasayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Plos One|May 22, 2013
TLR4 activates the β-catenin pathway to cause intestinal neoplasiaRebeca Santaolalla, Daniel A Sussman, Jose R Ruiz, et al.
BMC Musculoskeletal Disorders|February 13, 2014
Posterior short segment pedicle screw fixation and TLIF for the treatment of unstable thoracolumbar/lumbar fractureLing Wang, Jianjun Li, Hong Wang, et al.
Cancer Immunology Research|January 6, 2025
NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor ControlSara Majocchi, Pauline Lloveras, Lise Nouveau, et al.
Journal of Hematology & Oncology|December 13, 2023
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancersAnja Seckinger, Sara Majocchi, Valéry Moine, et al.
The Journal of Biological Chemistry|April 17, 2014
Selective antibody intervention of Toll-like receptor 4 activation through Fc γ receptor tetheringLimin Shang, Bruno Daubeuf, Martha Triantafilou, et al.
Molecular Cancer Therapeutics|May 11, 2018
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and LeukemiaVanessa Buatois, Zoë Johnson, Susana Salgado-Pires, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Transplantation|October 24, 2014
Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockadeLaurianne Giovannoni, Yannick D Muller, Stéphanie Lacotte, et al.
Cell Chemical Biology|October 21, 2021
An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunityYuehui Zhang, Limin Shang, Jing Zhang, et al.
Inflammatory Bowel Diseases|June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesisMasayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Plos One|May 22, 2013
TLR4 activates the β-catenin pathway to cause intestinal neoplasiaRebeca Santaolalla, Daniel A Sussman, Jose R Ruiz, et al.
BMC Musculoskeletal Disorders|February 13, 2014
Posterior short segment pedicle screw fixation and TLIF for the treatment of unstable thoracolumbar/lumbar fractureLing Wang, Jianjun Li, Hong Wang, et al.
Cancer Immunology Research|January 6, 2025
NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor ControlSara Majocchi, Pauline Lloveras, Lise Nouveau, et al.
Journal of Hematology & Oncology|December 13, 2023
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancersAnja Seckinger, Sara Majocchi, Valéry Moine, et al.
The Journal of Biological Chemistry|April 17, 2014
Selective antibody intervention of Toll-like receptor 4 activation through Fc γ receptor tetheringLimin Shang, Bruno Daubeuf, Martha Triantafilou, et al.
Molecular Cancer Therapeutics|May 11, 2018
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and LeukemiaVanessa Buatois, Zoë Johnson, Susana Salgado-Pires, et al.
Pageof 6